Emyria (ASX:EMD) Accounts Payable: A$0.84 Mil (As of Dec. 2025)


What is Emyria Accounts Payable?

Emyria ASX:EMD +7.89% Accounts Payable is A$0.84 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Emyria's Accounts Payable for the quarter that ended in Dec. 2025 was A$0.84 Mil.

Emyria's quarterly Accounts Payable declined from Dec. 2024 (A$0.73 Mil) to Jun. 2025 (A$0.37 Mil) but then increased from Jun. 2025 (A$0.37 Mil) to Dec. 2025 (A$0.84 Mil).

Emyria's annual Accounts Payable declined from Jun. 2023 (A$1.83 Mil) to Jun. 2024 (A$0.50 Mil) and declined from Jun. 2024 (A$0.50 Mil) to Jun. 2025 (A$0.37 Mil).

Emyria Accounts Payable Historical Data

* Premium members only.

The historical data trend for Emyria's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emyria Accounts Payable Chart

Emyria Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial 0.25 0.62 1.83 0.50 0.37

Emyria Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 0.50 0.73 0.37 0.84

Emyria Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$0.84 Mil mean?
Emyria (ASX:EMD) has a Accounts Payable of A$0.84 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Emyria and its competitors.
Is Emyria's Accounts Payable too high?
Emyria's current Accounts Payable is A$0.84 Mil.
How does Emyria's Accounts Payable compare to VEEV and BTSG?
Emyria's Accounts Payable of A$0.84 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Emyria and its competitors. Emyria's current Accounts Payable is A$0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emyria stock overvalued right now?
Based on GuruFocus' analysis, Emyria (ASX:EMD) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.04 — trading 36.7% above its estimated fair value. The current Accounts Payable is A$0.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Emyria (ASX:EMD), the current Accounts Payable is A$0.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emyria Business Description

Other Exchanges Q84:Germany
Address D2, 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.